Association between type 2 diabetes and depressive symptoms after a 1-year follow-up in an older adult Mediterranean population.
Depressive symptoms
HbA1c
Metabolic syndrome
Severity
Type 2 diabetes
Journal
Journal of endocrinological investigation
ISSN: 1720-8386
Titre abrégé: J Endocrinol Invest
Pays: Italy
ID NLM: 7806594
Informations de publication
Date de publication:
13 Jan 2024
13 Jan 2024
Historique:
received:
28
09
2023
accepted:
07
12
2023
medline:
14
1
2024
pubmed:
14
1
2024
entrez:
13
1
2024
Statut:
aheadofprint
Résumé
To examine the cross-sectional association between baseline depressive symptoms and the presence of type 2 diabetes (T2D), and its association with glycated hemoglobin (HbA1c) and other metabolic variables, and the prospective association of depressive symptoms and HbA1c after 1 year of follow-up. n = 6224 Mediterranean older adults with overweight/obesity and metabolic syndrome (48% females, mean age 64.9 ± 4.9 years) were evaluated in the framework of the PREDIMED-Plus study cohort. Depressive symptoms were assessed using the Beck Depression Inventory-II and HbA1c was used to measure metabolic control. The presence of T2D increased the likelihood of higher levels of depressive symptoms (χ This study supports an association between T2D and the severity of depressive symptoms, suggesting a worse metabolic control from mild severity levels in the short-medium term, influenced by lifestyle habits related to diabetes care. Screening for depressive symptoms and a multidisciplinary integrative therapeutic approach should be ensured in patients with T2D.
Identifiants
pubmed: 38218741
doi: 10.1007/s40618-023-02278-y
pii: 10.1007/s40618-023-02278-y
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Instituto de Salud Carlos III
ID : PI13/00673
Organisme : Instituto de Salud Carlos III
ID : PI13/00492
Organisme : Instituto de Salud Carlos III
ID : PI13/00272
Organisme : Instituto de Salud Carlos III
ID : PI13/01123
Organisme : Instituto de Salud Carlos III
ID : PI13/00462
Organisme : Instituto de Salud Carlos III
ID : PI13/00233
Organisme : Instituto de Salud Carlos III
ID : PI13/02184
Organisme : Instituto de Salud Carlos III
ID : PI13/00728
Organisme : Instituto de Salud Carlos III
ID : PI13/01090
Organisme : Instituto de Salud Carlos III
ID : PI13/01056
Organisme : Instituto de Salud Carlos III
ID : PI14/01722
Organisme : Instituto de Salud Carlos III
ID : PI14/00636
Organisme : Instituto de Salud Carlos III
ID : PI14/00618
Organisme : Instituto de Salud Carlos III
ID : PI14/00696
Organisme : Instituto de Salud Carlos III
ID : PI14/01206
Organisme : Instituto de Salud Carlos III
ID : PI14/01919
Organisme : Instituto de Salud Carlos III
ID : PI14/00853
Organisme : Instituto de Salud Carlos III
ID : PI14/01374
Organisme : Instituto de Salud Carlos III
ID : PI14/00972
Organisme : Instituto de Salud Carlos III
ID : PI14/00728
Organisme : Instituto de Salud Carlos III
ID : PI14/01471
Organisme : Instituto de Salud Carlos III
ID : PI16/00473
Organisme : Instituto de Salud Carlos III
ID : PI16/00662
Organisme : Instituto de Salud Carlos III
ID : PI16/01873
Organisme : Instituto de Salud Carlos III
ID : PI16/01094
Organisme : Instituto de Salud Carlos III
ID : PI16/00501
Organisme : Instituto de Salud Carlos III
ID : PI16/00533
Organisme : Instituto de Salud Carlos III
ID : PI16/00381
Organisme : Instituto de Salud Carlos III
ID : PI16/00366
Organisme : Instituto de Salud Carlos III
ID : PI16/01522
Organisme : Instituto de Salud Carlos III
ID : PI16/01120
Organisme : Instituto de Salud Carlos III
ID : PI17/00764
Organisme : Instituto de Salud Carlos III
ID : PI17/01183
Organisme : Instituto de Salud Carlos III
ID : PI17/00855
Organisme : Instituto de Salud Carlos III
ID : PI17/01347
Organisme : Instituto de Salud Carlos III
ID : PI17/00525
Organisme : Instituto de Salud Carlos III
ID : PI17/01827
Organisme : Instituto de Salud Carlos III
ID : PI17/00532
Organisme : Instituto de Salud Carlos III
ID : PI17/00215
Organisme : Instituto de Salud Carlos III
ID : PI17/01441
Organisme : Instituto de Salud Carlos III
ID : PI17/00508
Organisme : Instituto de Salud Carlos III
ID : PI17/01732
Organisme : Instituto de Salud Carlos III
ID : PI17/00926
Organisme : Instituto de Salud Carlos III
ID : PI19/00957
Organisme : Instituto de Salud Carlos III
ID : PI19/00386
Organisme : Instituto de Salud Carlos III
ID : PI19/00309
Organisme : Instituto de Salud Carlos III
ID : PI19/01032
Organisme : Instituto de Salud Carlos III
ID : PI19/00576
Organisme : Instituto de Salud Carlos III
ID : PI19/00017
Organisme : Instituto de Salud Carlos III
ID : PI19/01226
Organisme : Instituto de Salud Carlos III
ID : PI19/00781
Organisme : Instituto de Salud Carlos III
ID : PI19/01560
Organisme : Instituto de Salud Carlos III
ID : PI19/01332
Organisme : Instituto de Salud Carlos III
ID : PI20/01802
Organisme : Instituto de Salud Carlos III
ID : PI20/00138
Organisme : Instituto de Salud Carlos III
ID : PI20/01532
Organisme : Instituto de Salud Carlos III
ID : PI20/00456
Organisme : Instituto de Salud Carlos III
ID : PI20/00339
Organisme : Instituto de Salud Carlos III
ID : PI20/00557
Organisme : Instituto de Salud Carlos III
ID : PI20/00886
Organisme : Instituto de Salud Carlos III
ID : PI20/01158
Organisme : Instituto de Salud Carlos III
ID : CM21/00172
Organisme : Instituto de Salud Carlos III
ID : CD22/00171
Organisme : Generalitat Valenciana
ID : AICO/2021/347
Organisme : Generalitat Valenciana
ID : PROMETEO/21/2021
Organisme : Generalitat de Catalunya- AGAUR
ID : 2021-SGR-00824
Organisme : Horizon 2020 Framework Programme
ID : 847879
Organisme : Spanish Ministry of Economy, Industry and Competitiveness
ID : IJC2019-042420-I
Organisme : Universitat Rovira i Virgili
ID : 2020PMF-PIPF-37
Organisme : Consejería de Salud de la Junta de Andalucía
ID : PI0458/2013
Organisme : Consejería de Salud de la Junta de Andalucía
ID : PS0358/2016
Organisme : Consejería de Salud de la Junta de Andalucía
ID : PI0137/2018
Informations de copyright
© 2024. The Author(s).
Références
World Health Organization (2023) Diabetes—Fact Sheet. In: diabetes. https://www.who.int/news-room/fact-sheets/detail/diabetes . Accessed 29 Jun 2023
Soligo M, Morlacco A, Zattoni F et al (2022) Metabolic syndrome and stone disease. Panminerva Med 64:344–358. https://doi.org/10.23736/S0031-0808.21.04517-1
doi: 10.23736/S0031-0808.21.04517-1
pubmed: 34609121
Owens-Gary MD, Zhang X, Jawanda S et al (2019) The importance of addressing depression and diabetes distress in adults with type 2 diabetes. J Gen Intern Med 34:320–324. https://doi.org/10.1007/s11606-018-4705-2
doi: 10.1007/s11606-018-4705-2
pubmed: 30350030
Gois C, Akiskal H, Akiskal K, Luisa Figueira M (2012) Depressive temperament, distress, psychological adjustment and depressive symptoms in type 2 diabetes. J Affect Disord 143:1–4. https://doi.org/10.1016/j.jad.2012.05.028
doi: 10.1016/j.jad.2012.05.028
pubmed: 22901331
Dennick K, Sturt J, Speight J (2017) What is diabetes distress and how can we measure it? A narrative review and conceptual model. J Diabetes Complications 31:898–911
doi: 10.1016/j.jdiacomp.2016.12.018
pubmed: 28274681
Kim JR, Kim HN, Song SW (2018) Associations among inflammation, mental health, and quality of life in adults with metabolic syndrome. Diabetol Metab Syndr. https://doi.org/10.1186/s13098-018-0367-9
doi: 10.1186/s13098-018-0367-9
pubmed: 30186371
pmcid: 6119265
Limon VM, Lee M, Gonzalez B et al (2020) The impact of metabolic syndrome on mental health-related quality of life and depressive symptoms. Qual Life Res 29:2063–2072. https://doi.org/10.1007/s11136-020-02479-5
doi: 10.1007/s11136-020-02479-5
pubmed: 32215841
pmcid: 7513573
Harding KA, Pushpanathan ME, Whitworth SR et al (2019) Depression prevalence in type 2 diabetes is not related to diabetes–depression symptom overlap but is related to symptom dimensions within patient self-report measures: a meta-analysis. Diabet Med 36:1600–1611. https://doi.org/10.1111/dme.14139
doi: 10.1111/dme.14139
pubmed: 31532013
Wang F, Wang S, Zong QQ et al (2019) Prevalence of comorbid major depressive disorder in type 2 diabetes: a meta-analysis of comparative and epidemiological studies. Diabet Med 36:961–969. https://doi.org/10.1111/dme.14042
doi: 10.1111/dme.14042
pubmed: 31127631
Fugger G, Dold M, Bartova L et al (2019) Major depression and comorbid diabetes—findings from the European group for the study of resistant depression. Prog Neuro-Psychopharmacology Biol Psychiatry. https://doi.org/10.1016/j.pnpbp.2019.109638
doi: 10.1016/j.pnpbp.2019.109638
Mansur RB, Brietzke E, McIntyre RS (2015) Is there a “metabolic-mood syndrome”? A review of the relationship between obesity and mood disorders. Neurosci Biobehav Rev 52:89–104. https://doi.org/10.1016/j.neubiorev.2014.12.017
doi: 10.1016/j.neubiorev.2014.12.017
pubmed: 25579847
Postolache TT, del Bosque-Plata L, Jabbour S et al (2019) Co-shared genetics and possible risk gene pathway partially explain the comorbidity of schizophrenia, major depressive disorder, type 2 diabetes, and metabolic syndrome. Am J Med Genet Part B Neuropsychiatr Genet 180:186–203. https://doi.org/10.1002/ajmg.b.32712
doi: 10.1002/ajmg.b.32712
Pan A, Keum N, Okereke OI et al (2012) Bidirectional association between depression and metabolic syndrome: a systematic review and meta-analysis of epidemiological studies. Diabetes Care 35:1171–1180. https://doi.org/10.2337/dc11-2055
doi: 10.2337/dc11-2055
pubmed: 22517938
pmcid: 3329841
Martín-Peláez S, Serra-Majem L, Cano-Ibáñez N et al (2022) Contribution of cardio-vascular risk factors to depressive status in the predimed-plus trial. A cross-sectional and a 2-year longitudinal study. PLoS ONE 17:e0265079. https://doi.org/10.1371/journal.pone.0265079
doi: 10.1371/journal.pone.0265079
pubmed: 35417452
pmcid: 9007355
Pano O, Martínez-Lapiscina EH, Sayón-Orea C et al (2021) Healthy diet, depression and quality of life: a narrative review of biological mechanisms and primary prevention opportunities. World J Psychiatry 11:997–1016. https://doi.org/10.5498/wjp.v11.i11.997
doi: 10.5498/wjp.v11.i11.997
pubmed: 34888169
pmcid: 8613751
Mutz J, Lewis CM (2021) Lifetime depression and age-related changes in body composition, cardiovascular function, grip strength and lung function: sex-specific analyses in the UK Biobank. Aging (Albany NY) 13:17038–17079. https://doi.org/10.18632/aging.203275
doi: 10.18632/aging.203275
pubmed: 34233295
Mallorquí-Bagué N, Lozano-Madrid M, Toledo E et al (2018) Type 2 diabetes and cognitive impairment in an older population with overweight or obesity and metabolic syndrome: baseline cross-sectional analysis of the PREDIMED-plus study. Sci Rep. https://doi.org/10.1038/s41598-018-33843-8
doi: 10.1038/s41598-018-33843-8
pubmed: 30382190
pmcid: 6208341
Martínez-González MA, Sánchez-Villegas A (2016) Food patterns and the prevention of depression. Proc Nutr Soc 75:139–146. https://doi.org/10.1017/S0029665116000045
doi: 10.1017/S0029665116000045
pubmed: 26898781
Sánchez-Villegas A, Martínez-González MA, Estruch R et al (2013) Mediterranean dietary pattern and depression: the PREDIMED randomized trial. BMC Med 11:208. https://doi.org/10.1186/1741-7015-11-208
doi: 10.1186/1741-7015-11-208
pubmed: 24229349
pmcid: 3848350
Sánchez-Villegas A, Álvarez-Pérez J, Toledo E et al (2018) Seafood consumption, omega-3 fatty acids intake, and life-time prevalence of depression in the PREDIMED-plus trial. Nutrients. https://doi.org/10.3390/nu10122000
doi: 10.3390/nu10122000
pubmed: 30567286
pmcid: 6315981
Cano-Ibáñez N, Serra-Majem L, Martín-Peláez S et al (2022) Association between the prime diet quality score and depressive symptoms in a mediterranean population with metabolic syndrome. cross-sectional and 2-year follow-up assessment from predimed-plus study. Br J Nutr 128:1170–1179. https://doi.org/10.1017/S0007114521004323
doi: 10.1017/S0007114521004323
pubmed: 34713791
Alberti KGMM, Eckel RH, Grundy SM et al (2009) Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; Natioaanal heart, lung, and blood institute; American heart association; Woaarld heart federation; Internaaational. Circulation 120:1640–1645. https://doi.org/10.1161/CIRCULATIONAHA.109.192644
doi: 10.1161/CIRCULATIONAHA.109.192644
pubmed: 19805654
Martínez-González MA, Buil-Cosiales P, Corella D et al (2019) Cohort profile: design and methods of the predimed-plus randomized trial. Int J Epidemiol 48:387–388o. https://doi.org/10.1093/IJE/DYY225
doi: 10.1093/IJE/DYY225
pubmed: 30476123
Beck AT, Steer RA, Brown GK (1996) Manual for the beck depression inventory-II. San Antonio, TX Psychol Corp 1:82
Sanz J, Perdigón AL, Vázquez C (2003) Adaptación española del Inventario para la Depresión de Beck-II (BDI-II): 2. Propiedades psicométricas en población general | Revista de psicología. Clínica y Salud 14:249–280
Feldman H, ElSayed NA, McCoy RG et al (2023) Standards of care in diabetes—2023 abridged for primary care providers. Clin Diabetes 41:4–31. https://doi.org/10.2337/cd23-as01
doi: 10.2337/cd23-as01
Schröder H, Zomeño MD, Martínez-González MA et al (2021) Validity of the energy-restricted mediterranean diet adherence screener. Clin Nutr 40:4971–4979. https://doi.org/10.1016/j.clnu.2021.06.030
doi: 10.1016/j.clnu.2021.06.030
pubmed: 34364236
Molina L, Sarmiento M, Peñafiel J et al (2017) Validation of the regicor short physical activity questionnaire for the adult population. PLoS ONE 12:e0168148. https://doi.org/10.1371/JOURNAL.PONE.0168148
doi: 10.1371/JOURNAL.PONE.0168148
pubmed: 28085886
pmcid: 5234797
StataCorp LLC (2021) Stata statistical software: Release 17. College Station, TX
Finner H, Roters M (2001) On the false discovery rate and expected type I errors. Biometrical J 43:985–1005. https://doi.org/10.1002/1521-4036(200112)43:8%3c985::AID-BIMJ985%3e3.0.CO;2-4
doi: 10.1002/1521-4036(200112)43:8<985::AID-BIMJ985>3.0.CO;2-4
Gonzalez JS, Hood KK, Esbitt SA, et al (2018) Psychiatric and psychosocial issues among individuals living with diabetes. In: Cowie CC et al (eds) Diabetes in America. 3rd edn, Chapter 33. National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, pp 1–34
Cantero I, Abete I, Babio N et al (2018) Dietary inflammatory index and liver status in subjects with different adiposity levels within the predimed trial. Clin Nutr 37:1736–1743. https://doi.org/10.1016/j.clnu.2017.06.027
doi: 10.1016/j.clnu.2017.06.027
pubmed: 28734553
Moulton CD, Pickup JC, Ismail K (2015) The link between depression and diabetes: the search for shared mechanisms. Lancet Diabetes Endocrinol 3:461–471. https://doi.org/10.1016/S2213-8587(15)00134-5
doi: 10.1016/S2213-8587(15)00134-5
pubmed: 25995124
Martins LB, Braga Tibães JR, Berk M, Teixeira AL (2022) Diabetes and mood disorders: shared mechanisms and therapeutic opportunities. Int J Psychiatry Clin Pract 26:183–195. https://doi.org/10.1080/13651501.2021.1957117
doi: 10.1080/13651501.2021.1957117
pubmed: 34348557
Holt RIG, De Groot M, Golden SH (2014) Diabetes and depression. Curr Diab Rep. https://doi.org/10.1007/s11892-014-0491-3
doi: 10.1007/s11892-014-0491-3
pubmed: 24743941
pmcid: 4476048
Lyra e Silva N de M, Lam MP, Soares CN, et al (2019) Insulin resistance as a shared pathogenic mechanism between depression and type 2 diabetes. Front Psychiatry 10:57
doi: 10.3389/fpsyt.2019.00057
pubmed: 30837902
Doyle T, Halaris A, Rao M (2014) Shared neurobiological pathways between type 2 diabetes and depressive symptoms: a review of morphological and neurocognitive findings. Curr Diab Rep 14:1–12. https://doi.org/10.1007/s11892-014-0560-7
doi: 10.1007/s11892-014-0560-7
Dantzer R, O’Connor JC, Freund GG et al (2008) From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 9:46–56
doi: 10.1038/nrn2297
pubmed: 18073775
pmcid: 2919277
Amare AT, Schubert KO, Klingler-Hoffmann M et al (2017) The genetic overlap between mood disorders and cardiometabolic diseases: a systematic review of genome wide and candidate gene studies. Transl Psychiatry. https://doi.org/10.1038/tp.2016.261
doi: 10.1038/tp.2016.261
pubmed: 28117839
pmcid: 5545727
Reynolds KA, Helgeson VS (2011) Children with diabetes compared to peers: depressed? Distressed? A meta-analytic review. Ann Behav Med 42:29–41. https://doi.org/10.1007/s12160-011-9262-4
doi: 10.1007/s12160-011-9262-4
pubmed: 21445720
Fisher L, Glasgow RE, Strycker LA (2010) The relationship between diabetes distress and clinical depression with glycemic control among patients with type 2 diabetes. Diabetes Care 33:1034–1036. https://doi.org/10.2337/dc09-2175
doi: 10.2337/dc09-2175
pubmed: 20150291
pmcid: 2858170
Gonzalez JS, Safren SA, Cagliero E et al (2007) Depression, self-care, and medication adherence in type 2 diabetes: relationships across the full range of symptom severity. Diabetes Care 30:2222–2227. https://doi.org/10.2337/dc07-0158
doi: 10.2337/dc07-0158
pubmed: 17536067
Paans NPG, Bot M, Brouwer IA et al (2018) The association between depression and eating styles in four European countries: the MooDFOOD prevention study. J Psychosom Res 108:85–92. https://doi.org/10.1016/j.jpsychores.2018.03.003
doi: 10.1016/j.jpsychores.2018.03.003
pubmed: 29602330
Mills JG, Thomas SJ, Larkin TA, Deng C (2020) Overeating and food addiction in major depressive disorder: links to peripheral dopamine. Appetite. https://doi.org/10.1016/j.appet.2020.104586
doi: 10.1016/j.appet.2020.104586
pubmed: 32768601
Wermeling M, Thiele-Manjali U, Koschack J et al (2014) Type 2 diabetes patients’ perspectives on lifestyle counselling and weight management in general practice: a qualitative study. BMC Fam Pract. https://doi.org/10.1186/1471-2296-15-97
doi: 10.1186/1471-2296-15-97
pubmed: 24885605
pmcid: 4027991
Kane NS, Hoogendoorn CJ, Tanenbaum ML, Gonzalez JS (2018) Physical symptom complaints, cognitive emotion regulation strategies, self-compassion and diabetes distress among adults with type 2 diabetes. Diabet Med 35:1671–1677. https://doi.org/10.1111/dme.13830
doi: 10.1111/dme.13830
pubmed: 30264898
pmcid: 7313242
Rubin RR, Peyrot M (2001) Psychological issues and treatments for people with diabetes. J Clin Psychol 57:457–478. https://doi.org/10.1002/jclp.1041
doi: 10.1002/jclp.1041
pubmed: 11255202
Olesen K, Folmann Hempler N, Drejer S et al (2020) Impact of patient-centred diabetes self-management education targeting people with type 2 diabetes: an integrative review. Diabet Med 37:909–923. https://doi.org/10.1111/dme.14284
doi: 10.1111/dme.14284
pubmed: 32124483
Cheng L, Sit JWH, Choi K, chow, et al (2018) Effectiveness of a patient-centred, empowerment-based intervention programme among patients with poorly controlled type 2 diabetes: a randomised controlled trial. Int J Nurs Stud 79:43–51. https://doi.org/10.1016/j.ijnurstu.2017.10.021
doi: 10.1016/j.ijnurstu.2017.10.021
pubmed: 29149618
White RL, Babic MJ, Parker PD et al (2017) Domain-specific physical activity and mental health: a meta-analysis. Am J Prev Med 52:653–666. https://doi.org/10.1016/j.amepre.2016.12.008
doi: 10.1016/j.amepre.2016.12.008
pubmed: 28153647
Carter J, Swardfager W (2016) Mood and metabolism: anhedonia as a clinical target in type 2 diabetes. Psychoneuroendocrinology 69:123–132. https://doi.org/10.1016/j.psyneuen.2016.04.002
doi: 10.1016/j.psyneuen.2016.04.002
pubmed: 27088371
Hoffmann MS, Brunoni AR, Stringaris A et al (2021) Common and specific aspects of anxiety and depression and the metabolic syndrome. J Psychiatr Res 137:117–125. https://doi.org/10.1016/j.jpsychires.2021.02.052
doi: 10.1016/j.jpsychires.2021.02.052
pubmed: 33677215
Vancampfort D, Firth J, Schuch FB et al (2017) Sedentary behavior and physical activity levels in people with schizophrenia, bipolar disorder and major depressive disorder: a global systematic review and meta-analysis. World Psychiatry 16:308–315. https://doi.org/10.1002/wps.20458
doi: 10.1002/wps.20458
pubmed: 28941119
pmcid: 5608847
Mikkelsen K, Stojanovska L, Polenakovic M et al (2017) Exercise and mental health. Maturitas 106:48–56. https://doi.org/10.1016/j.maturitas.2017.09.003
doi: 10.1016/j.maturitas.2017.09.003
pubmed: 29150166
Schmidt CB, van Loon BJP, Vergouwen ACM et al (2018) Systematic review and meta-analysis of psychological interventions in people with diabetes and elevated diabetes-distress. Diabet Med 35:1157–1172. https://doi.org/10.1111/dme.13709
doi: 10.1111/dme.13709
American Diabetes Association (ADA) (2023) Mental health toolkit | American diabetes association. In: diabetes. https://professional.diabetes.org/meetings/mental-health-toolkit . Accessed 29 Jun 2023
Jacka FN, O’Neil A, Opie R et al (2017) A randomised controlled trial of dietary improvement for adults with major depression (the “SMILES” trial). BMC Med. https://doi.org/10.1186/s12916-017-0791-y
doi: 10.1186/s12916-017-0791-y
pubmed: 28137247
pmcid: 5282719